Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Brain protection--human data and potential new therapies

L B Morgenstern1, L C Pettigrew

  • 1Department of Neurology and The Epidemiology Research Center, University of Texas, Houston 77030, USA.

New Horizons (Baltimore, Md.)
|January 20, 1998
PubMed
Summary

Neuroprotective therapies aim to protect brain cells during acute ischemic stroke by interrupting the damaging cascade. Promising agents are nearing clinical use, offering new hope for stroke treatment alongside existing therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diabetes and ischaemic stroke outcome.

Diabetic medicine : a journal of the British Diabetic Association·2018
Same author

Higher mortality in patients with right hemispheric intracerebral haemorrhage: INTERACT1 and 2.

Journal of neurology, neurosurgery, and psychiatry·2015
Same author

Setting priorities for stroke care and research.

International journal of stroke : official journal of the International Stroke Society·2013
Same author

Enrollment of women and minorities in NINDS trials.

Neurology·2011
Same author

Do-not-resuscitate orders and predictive models after intracerebral hemorrhage.

Neurology·2010
Same author

Significance of perihematomal edema in acute intracerebral hemorrhage: the INTERACT trial.

Neurology·2009

Area of Science:

  • Neurology
  • Cerebrovascular Diseases
  • Neuroprotection

Background:

  • Acute ischemic stroke research focuses on neuroprotective therapies.
  • Several agents show promise as standalone or adjunct treatments to thrombolysis.
  • Cytoprotective therapy targets the ischemic cascade in penumbral tissue.

Purpose of the Study:

  • To review the progress of neuroprotective agents for acute ischemic stroke.
  • To highlight the mechanisms of the ischemic cascade and therapeutic targets.
  • To discuss the potential clinical application of emerging neuroprotective strategies.

Main Methods:

  • Review of animal and human research on neuroprotective agents.
  • Analysis of therapeutic strategies targeting the ischemic cascade.
  • Examination of clinical trial progress for neuroprotective agents.

Main Results:

  • Neuroprotective agents target key steps in the ischemic cascade, including ion pump failure, excitotoxicity, and calcium influx.
  • Human clinical trials have advanced for agents inhibiting excitatory amino acid injury, free radical damage, and calcium accumulation.
  • These therapies hold significant promise for acute ischemic stroke management.

Conclusions:

  • Neuroprotective agents are nearing clinical availability for acute ischemic stroke.
  • Further research continues to refine these promising therapeutic strategies.
  • The clinical use of neuroprotective agents is anticipated soon.

Related Experiment Videos